BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 5, 2000
View Archived Issues
Phase II results reported for tenofovir DF
Read More
Pivotal trial of Fabrazyme meets primary endpoint
Read More
Medarex and Centocor sign antibody development agreement
Read More
Transgenic antibody production agreement signed by Genzyme Transgenics and Abgenix
Read More
LigoCyte awarded Phase II SBIR grant for nanoparticle technology
Read More
Connetics continues to expand relaxin indications
Read More
Corixa expands technology through five new collaborative agreements
Read More
Q1 2000 marked by significant achievements at Elan
Read More
AxyS makes considerable progress in drug discovery and development programs during Q1 2000
Read More
Anti-human CD40 antibodies designed by BMS for use in immune disorders and inflammation
Read More
Final results of phase I/IIa trial evaluating CAT-152 in trabeculectomy patients announced at ARVO
Read More
Isis prepares antisense modulators of FAN expression
Read More
Schering prepares new fluorescent contrast agents for imaging tumors and blood vessels
Read More
News from ARVO: ISV-205 reduces corticosteroid-induced IOP elevations
Read More
Novel antifungal agent derived from BPI under study at Xoma
Read More
Tau protein kinase 1 inhibitors in development at Mitsubishi-Tokyo Pharmaceuticals
Read More
Oxazolidines and thiazolidines claimed by Roche Diagnostics for bone disorders
Read More
Preparation and biological evaluation of Cubist's new tRNA synthetase inhibitors described
Read More
New heterocyclic compounds from Procter & Gamble particularly useful for alopecia
Read More
Profile of KUL-7211, a new beta-adrenoceptor agonist with selectivity for ureteral smooth muscle
Read More
Actin polymerization inducer jasplakinolide improves outflow facility in primate model
Read More
Early clinical trial results in BPH suggest promise of new highly selective alpha1A blocker
Read More
A-204176 may increase IUP without cardiovascular side effects according to preclinical data
Read More
Clinical development of Neotrofin for AD reviewed at recent symposium
Read More
Celecoxib examined for effects on progression of AD in elderly in a 52-week study
Read More
Novel antiinflammatory drug tested in Sweden for efficacy in Alzheimer's disease
Read More
Nucleoside analogues with activity against herpesviruses developed by Japanese research team
Read More
No consistent cognitive or motor effects detected for SIB-1508Y in safety study in early PD
Read More
